BofA Securities initiated coverage on VectivBio with a new price target

5/4/21 6:59:17 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

BofA Securities initiated coverage of VectivBio with a rating of Buy and set a new price target of $19.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VECT

Date	Price Target	Rating	Analyst
12/13/2022	$18.00	Buy	Jefferies
7/1/2022	$23.00	Overweight	Piper Sandler